Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1588091866', 'doi': 'https://doi.org/10.1158/1538-7445.am2014-1881', 'title': 'Abstract 1881: New therapeutic options for CLL treatment: Src/c-abl-directed molecular re-engineering of chlorambucil and bendamustine', 'display_name': 'Abstract 1881: New therapeutic options for CLL treatment: Src/c-abl-directed molecular re-engineering of chlorambucil and bendamustine', 'publication_year': 2014, 'publication_date': '2014-10-01', 'ids': {'openalex': 'https://openalex.org/W1588091866', 'doi': 'https://doi.org/10.1158/1538-7445.am2014-1881', 'mag': '1588091866'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2014-1881', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027266640', 'display_name': 'Lilian Amrein', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801824472', 'display_name': 'Jewish General Hospital', 'ror': 'https://ror.org/056jjra10', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801824472']}, {'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lilian Amrein', 'raw_affiliation_strings': ['1Segal Cancer Center/Jewish General Institute/McGill University, Montreal, Quebec, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Segal Cancer Center/Jewish General Institute/McGill University, Montreal, Quebec, Canada;', 'institution_ids': ['https://openalex.org/I2801824472', 'https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020333712', 'display_name': 'Anne-Laure Larocque', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}, {'id': 'https://openalex.org/I4210088756', 'display_name': 'Royal Victoria Hospital', 'ror': 'https://ror.org/00arwy491', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801766832', 'https://openalex.org/I4210088756']}, {'id': 'https://openalex.org/I2799616883', 'display_name': 'Royal Victoria Regional Health Centre', 'ror': 'https://ror.org/01r89q997', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799616883']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Anne-Laure Larocque', 'raw_affiliation_strings': ['2The Cancer Drug Research Laboratory, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada;'], 'affiliations': [{'raw_affiliation_string': '2The Cancer Drug Research Laboratory, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada;', 'institution_ids': ['https://openalex.org/I5023651', 'https://openalex.org/I4210088756', 'https://openalex.org/I2799616883']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042063888', 'display_name': 'David Davidson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801824472', 'display_name': 'Jewish General Hospital', 'ror': 'https://ror.org/056jjra10', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801824472']}, {'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'David Davidson', 'raw_affiliation_strings': ['1Segal Cancer Center/Jewish General Institute/McGill University, Montreal, Quebec, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Segal Cancer Center/Jewish General Institute/McGill University, Montreal, Quebec, Canada;', 'institution_ids': ['https://openalex.org/I2801824472', 'https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036446709', 'display_name': 'Lisa Peyrard', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2799616883', 'display_name': 'Royal Victoria Regional Health Centre', 'ror': 'https://ror.org/01r89q997', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799616883']}, {'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}, {'id': 'https://openalex.org/I4210088756', 'display_name': 'Royal Victoria Hospital', 'ror': 'https://ror.org/00arwy491', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801766832', 'https://openalex.org/I4210088756']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lisa Peyrard', 'raw_affiliation_strings': ['2The Cancer Drug Research Laboratory, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada;'], 'affiliations': [{'raw_affiliation_string': '2The Cancer Drug Research Laboratory, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada;', 'institution_ids': ['https://openalex.org/I2799616883', 'https://openalex.org/I5023651', 'https://openalex.org/I4210088756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036550264', 'display_name': 'Daniel Borrelli', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Daniel Borrelli', 'raw_affiliation_strings': ['#N# 3McGill University, Montreal, Quebec, Canada'], 'affiliations': [{'raw_affiliation_string': '#N# 3McGill University, Montreal, Quebec, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005009665', 'display_name': 'Bertrand J. Jean‐Claude', 'orcid': 'https://orcid.org/0000-0002-4312-6485'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}, {'id': 'https://openalex.org/I4210088756', 'display_name': 'Royal Victoria Hospital', 'ror': 'https://ror.org/00arwy491', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801766832', 'https://openalex.org/I4210088756']}, {'id': 'https://openalex.org/I2799616883', 'display_name': 'Royal Victoria Regional Health Centre', 'ror': 'https://ror.org/01r89q997', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799616883']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Bertrand Jean-Claude', 'raw_affiliation_strings': ['2The Cancer Drug Research Laboratory, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada;'], 'affiliations': [{'raw_affiliation_string': '2The Cancer Drug Research Laboratory, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada;', 'institution_ids': ['https://openalex.org/I5023651', 'https://openalex.org/I4210088756', 'https://openalex.org/I2799616883']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049481562', 'display_name': 'Lawrence Panasci', 'orcid': 'https://orcid.org/0000-0002-5141-5594'}, 'institutions': [{'id': 'https://openalex.org/I2801824472', 'display_name': 'Jewish General Hospital', 'ror': 'https://ror.org/056jjra10', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801824472']}, {'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lawrence Panasci', 'raw_affiliation_strings': ['1Segal Cancer Center/Jewish General Institute/McGill University, Montreal, Quebec, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Segal Cancer Center/Jewish General Institute/McGill University, Montreal, Quebec, Canada;', 'institution_ids': ['https://openalex.org/I2801824472', 'https://openalex.org/I5023651']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': '74', 'issue': '19_Supplement', 'first_page': '1881', 'last_page': '1881'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.976, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9449, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/chlorambucil', 'display_name': 'Chlorambucil', 'score': 0.8576604}, {'id': 'https://openalex.org/keywords/nitrogen-mustard', 'display_name': 'Nitrogen mustard', 'score': 0.51521903}, {'id': 'https://openalex.org/keywords/bendamustine', 'display_name': 'Bendamustine', 'score': 0.4618183}], 'concepts': [{'id': 'https://openalex.org/C2777866208', 'wikidata': 'https://www.wikidata.org/wiki/Q415939', 'display_name': 'Chlorambucil', 'level': 4, 'score': 0.8576604}, {'id': 'https://openalex.org/C2777938653', 'wikidata': 'https://www.wikidata.org/wiki/Q1088156', 'display_name': 'Chronic lymphocytic leukemia', 'level': 3, 'score': 0.62580645}, {'id': 'https://openalex.org/C2779263901', 'wikidata': 'https://www.wikidata.org/wiki/Q185916', 'display_name': 'Fludarabine', 'level': 4, 'score': 0.6253221}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5908753}, {'id': 'https://openalex.org/C2779536868', 'wikidata': 'https://www.wikidata.org/wiki/Q419940', 'display_name': 'Dasatinib', 'level': 4, 'score': 0.5873168}, {'id': 'https://openalex.org/C2778670039', 'wikidata': 'https://www.wikidata.org/wiki/Q414004', 'display_name': 'Nitrogen mustard', 'level': 4, 'score': 0.51521903}, {'id': 'https://openalex.org/C2781442060', 'wikidata': 'https://www.wikidata.org/wiki/Q425745', 'display_name': 'Bendamustine', 'level': 4, 'score': 0.4618183}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.44901037}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4460962}, {'id': 'https://openalex.org/C2777583451', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib', 'level': 3, 'score': 0.4297986}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.40472433}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.38566363}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.29417735}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.24642974}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.17052025}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.15135136}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.08702016}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2014-1881', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.8}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3140729390', 'https://openalex.org/W2558553681', 'https://openalex.org/W2419406204', 'https://openalex.org/W2326175431', 'https://openalex.org/W2247136531', 'https://openalex.org/W2163348695', 'https://openalex.org/W2114753349', 'https://openalex.org/W2067030170', 'https://openalex.org/W2047982141', 'https://openalex.org/W1998954504'], 'abstract_inverted_index': {'Abstract': [0], 'B-cell': [1], 'chronic': [2], 'lymphocytic': [3], 'leukemia': [4], '(CLL)': [5], 'is': [6], 'characterized': [7], 'by': [8, 329], 'actively': [9], 'dividing': [10], 'B-lymphocytes': [11, 358], 'in': [12, 26, 180, 211, 354, 356, 376, 406], 'the': [13, 21, 27, 50, 59, 76, 84, 99, 125, 174, 186, 208, 229, 236, 247, 255, 284, 309, 330, 333, 337, 351, 398, 415, 463, 468], 'lymph': [14, 88], 'nodes': [15], 'and': [16, 44, 71, 87, 157, 198, 241, 254, 274, 292, 306, 321, 345, 385, 390, 402, 419, 457], 'bone': [17, 85], 'marrow,': [18], 'associated': [19], 'with': [20, 54, 66, 80, 259, 308, 312, 378], 'accumulation': [22], 'of': [23, 30, 52, 78, 102, 119, 124, 176, 189, 194, 235, 238, 249, 257, 286, 288, 302, 314, 336, 341, 400, 427, 455, 462, 467], 'quiescent': [24], 'lymphocytes': [25, 93, 139, 214, 221], 'peripheral': [28], 'blood': [29], 'affected': [31], 'patients.': [32, 362, 429], 'Current': [33], 'treatments': [34], 'for': [35, 75, 397, 425, 449, 471], 'this': [36, 367], 'disease': [37], 'include': [38], 'chemotherapeutic': [39, 109], '(chlorambucil': [40], '(CLB),': [41], 'cyclophosphamide,': [42], 'fludarabine)': [43], 'immunotherapeutic': [45], 'agents': [46], '(Rituximab,': [47], 'Alemtuzumab)': [48], 'or': [49, 134], 'combination': [51, 175, 256, 377], 'immunotherapy': [53], 'chemotherapeutics': [55], 'drugs.': [56, 110], 'In': [57], '2008,': [58], 'FDA': [60], 'approved': [61], 'bendamustine,': [62], 'a': [63, 67, 72, 147, 163, 168, 195, 199, 342, 346, 370, 407], 'bifunctional': [64], 'agent': [65], 'nitrogen': [68, 164], 'mustard': [69, 165], 'moiety': [70, 197, 205, 344], 'purine': [73], 'analog,': [74], 'treatment': [77, 98, 426], 'patients': [79], 'CLL.': [81], 'Signals': [82], 'from': [83, 94, 222, 359], 'marrow': [86], 'node': [89], 'microenvironments': [90], 'protect': [91], 'CLL': [92, 138, 181, 213, 220, 224, 361, 408, 428, 450], 'drug-induced': [95], 'apoptosis.': [96], 'During': [97], 'enzyme-mediated': [100], 'repair': [101, 128], 'DNA': [103, 160, 315], 'damage': [104, 161, 316], 'can': [105], 'induce': [106, 159], 'resistance': [107], 'to': [108, 140, 150, 158, 207, 350, 393], 'We': [111, 142, 326], 'have': [112], 'previously': [113], 'shown': [114], 'that': [115, 145, 228, 283, 366, 414], 'small': [116], 'molecule': [117], 'inhibitors': [118], 'c-abl': [120, 152], '(a': [121, 201], 'key': [122], 'protein': [123], 'homologous': [126], 'recombinational': [127], 'pathway)': [129], 'such': [130], 'as': [131], 'imatinib,': [132], 'nilotinib': [133], 'dasatinib,': [135], 'sensitize': [136], 'primary': [137, 212, 357], 'CLB.': [141], 'also': [143, 327], 'demonstrated': [144, 365], 'ZRF4,': [146], 'combi-molecule': [148, 338, 368], 'designed': [149], 'target': [151], '(through': [153, 162], 'an': [154], 'imatinib': [155, 179], 'moiety)': [156], 'moiety),': [166], 'has': [167, 369], 'more': [169], 'potent': [170], 'cytotoxic': [171, 334], 'effect': [172, 188, 335], 'than': [173, 246, 374], 'CLB': [177, 250, 258, 291, 293], 'plus': [178, 294], 'lymphocytes.': [182], 'Here': [183], 'we': [184, 226], 'report': [185], 'anticancer': [187, 372], 'three': [190], 'different': [191], 'combi-molecules': [192, 416], 'composed': [193, 340], 'chlorambucil': [196, 456], 'dasatinib': [200, 262, 295, 347, 381], 'dual': [202], 'Src/c-abl': [203], 'inhibitor)': [204], 'compare': [206, 349], 'individual': [209, 352], 'components': [210, 353], 'in-vitro.': [215], 'Using': [216], 'MTT': [217, 331], 'assays': [218], 'on': [219], '40': [223], 'patients,': [225], 'found': [227], 'IC50': [230, 248], '(concentration': [231], 'which': [232], 'kills': [233], '50%': [234], 'cells)': [237], 'AL748,': [239], 'AL758': [240], 'AL816': [242], 'are': [243, 388], 'significantly': [244], 'lower': [245], 'when': [251], 'used': [252], 'alone': [253], '0.1': [260, 379], 'μM': [261, 273, 276, 380], '(median': [263], 'value': [264], '=': [265], '1.7': [266], 'μM,': [267, 269, 271], '0.6': [268], '0.9': [270], '11': [272], '3.1': [275], 'respectively).': [277], 'Moreover,': [278], 'our': [279], 'biochemical': [280], 'results': [281, 364, 412], 'suggest': [282, 413], 'mechanism': [285], 'action': [287], 'AL758,': [289, 417], 'AL816,': [290, 418], 'share': [296], 'common': [297], 'downstream': [298], 'targets': [299], 'including': [300], 'inhibition': [301], 'Src': [303], 'kinase,': [304], 'chemotaxis,': [305], 'cross-talk': [307], 'microenvironment': [310], 'along': [311], 'induction': [313], '(p53,': [317], 'p21,': [318], 'comet': [319], 'assay)': [320], 'apoptosis': [322], '(AnnexinV,': [323], 'cleaved': [324], 'caspase-3).': [325], 'determined,': [328], 'assay,': [332], 'AL887': [339, 420], 'bendamustine': [343, 375], 'moiety,': [348], 'vitro': [355], '20': [360], 'Our': [363, 411], 'better': [371], 'activity': [373], '(p<0.0005).': [382], 'Dose-limiting': [383], 'toxicity': [384], 'drug': [386], 'pharmacokinetics': [387], 'important': [389], 'limiting': [391], 'factors': [392], 'take': [394], 'into': [395], 'account': [396], 'development': [399], 'chemotherapy': [401], 'will': [403], 'be': [404, 422], 'tested': [405], 'mouse': [409], 'model.': [410], 'may': [421], 'useful': [423], 'alternatives': [424], 'Citation': [430], 'Format:': [431], 'Lilian': [432], 'Amrein,': [433], 'Anne-Laure': [434], 'Larocque,': [435], 'David': [436], 'Davidson,': [437], 'Lisa': [438], 'Peyrard,': [439], 'Daniel': [440], 'Borrelli,': [441], 'Bertrand': [442], 'Jean-Claude,': [443], 'Lawrence': [444], 'Panasci.': [445], 'New': [446], 'therapeutic': [447], 'options': [448], 'treatment:': [451], 'Src/c-abl-directed': [452], 'molecular': [453], 're-engineering': [454], 'bendamustine.': [458], '[abstract].': [459], 'In:': [460], 'Proceedings': [461], '105th': [464], 'Annual': [465], 'Meeting': [466], 'American': [469], 'Association': [470], 'Cancer': [472, 483], 'Research;': [473], '2014': [474], 'Apr': [475], '5-9;': [476], 'San': [477], 'Diego,': [478], 'CA.': [479], 'Philadelphia': [480], '(PA):': [481], 'AACR;': [482], 'Res': [484], '2014;74(19': [485], 'Suppl):Abstract': [486], 'nr': [487], '1881.': [488], 'doi:10.1158/1538-7445.AM2014-1881': [489]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1588091866', 'counts_by_year': [], 'updated_date': '2024-12-08T12:59:58.634211', 'created_date': '2016-06-24'}